The European Joint Programme on Rare Diseases, alongside TRANSCAN and the Innovative Health Initiative were selected by ERA LEARN to investigate how partnerships navigate the process of translating research activities into medical and health innovations for the benefit of patients, the European health systems and society.
The aim of this policy brief consists of setting up a methodological approach to understanding translation of research into innovative outcomes. Studies on knowledge transfer and innovation processes often come across the idea of “the valley of death”, that is the critical phase where one step of the innovation process ends and a new one begins. In this perspective, one of the roles of partnerships is to bridge this valley of death by linking excellent research with technology and solution-minded business undertakings hence generating virtuous cycles of research and innovation.
